This is an outdated version published on 2021-04-06. Read the most recent version.

Efficacy and Safety of a Diabetes Specific Formula in Patients with Type 2 Diabetes Mellitus: A Randomized, Open-label, Crossover Study.

Authors

  • Pariya Phanachet Division of Nutrition & Biochemical Medicine, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
  • Prapimporn Chattranukulchai Shantavasinkul Division of Nutrition & Biochemical Medicine, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
  • Tanarat Lepananon Division of Nutrition & Biochemical Medicine, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
  • Naphat Taonam Division of Nutrition & Biochemical Medicine, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
  • Wanabhorn Tongchom Graduate Program in Nutrition, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
  • Jariya Boonpattararaksa Nutrition and Dietetics Unit, Ramathibodi Chakri Naruebodindra Hospital, Mahidol University, Bangkok, Thailand
  • Nantaporn Sittikho Division of Nutrition & Biochemical Medicine, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
  • Orawan Pichitchaipitak 4Home Health Care Nursing Unit, Division of Ambulatory Care Nursing Service, Department of Nursing, Faculty of Medicine Ramathibodi, Hospital, Mahidol University, Bangkok, Thailand
  • Nantanat Tontrakulrat Division of Nutrition & Biochemical Medicine, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
  • Andrea Hawkinson Nestlé Health Science, Metabolic Health, United States
  • Daruneewan Warodomwichit Division of Nutrition & Biochemical Medicine, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok

Keywords:

Diabetes, Diabetes specific formula, Postprandial glucose, Insulin, Glycemic index

Abstract

Managing postprandial hyperglycemia is a frequent challenge for individuals with Type 2 diabetes (T2D). There is a paucity of data examining use of a diabetes-specific formula (DSF) versus a matched isocaloric diet and improved PPG. The present study aimed to evaluate the effects of a new DSF compared to a matched macronutrient isocaloric diet on postprandial glucose (PPG), insulin, and safety in patients with T2D. In this randomized, open-label, crossover study, 30 T2D subjects were randomized into one of two groups: group A received the new DSF and group B received the isocaloric diet. After one-week, participants crossed over to the alternative nutrition intervention. Blood samples measured glucose and insulin levels at baseline, 30, 60, and 120 min post-meal. PPG levels and incremental area under the curve (iAUC) for glucose were significantly lower for group A compared to group B (P=0.007). Postprandial insulin levels were lower at 60 and 120 min for group A compared to group B, though not statistically different. The DSF was well tolerated and no serious adverse events were reported. This study demonstrates that use of a DSF is superior to an isocaloric diet in reducing PPG and tend to improving insulin response in T2D patients. These data suggest use of a DSF offers glycemic benefits and should be included as a medical nutrition therapy for patients with Type 2 diabetes.

References

International Diabetes Federation, 2017 [Internet]. IDF Diabetes Atlas, 8th edn. 2017 [Cited 10 April 2019]. Available from: https://www.diabetesatlas.org/upload/resources/previous/files/8/IDF_DA_8e-EN-final.pdf

Aekplakorn W, Chariyalertsak S, Kessomboon P, Assanangkornchai S, Taneepanichskul S, Putwatana P. Prevalence of Diabetes and Relationship with Socioeconomic Status in the Thai Population: National Health Examination Survey, 2004-2014. J Diabetes Res. 2018; 2018:1654530.

Strategy and Planning Division Ministry of Public Health [Internet]. Nonthaburi: Statistical Thailand 2017; 2017 [cited 2021 Feb 4]. Available from: http://www.hed.go.th/menuHome/file/529

Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care. 2003; 26(3):881-5.

Jenkins DJ, Wolever TM, Taylor RH, Barker H, Fielden H, Baldwin JM, et al. Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr. 1981; 34(3):362-6.

Lina BA, Jonker D, Kozianowski G. Isomaltulose (Palatinose): a review of biological and toxicological studies. Food Chem Toxicol. 2002; 40(10):1375-81.

Atkinson FS, Foster-Powell K, Brand-Miller JC. International tables of glycemic index and glycemic load values: 2008. Diabetes Care. 2008; 31(12):2281-3.

Wang Y, Chen J, Song YH, Zhao R, Xia L, Chen Y, et al. Effects of the resistant starch on glucose, insulin, insulin resistance, and lipid parameters in overweight or obese adults: a systematic review and meta-analysis. Nutr Diabetes. 2019; 9(1):19.

Ojo O, Ojo OO, Adebowale F, Wang XH. The Effect of Dietary Glycaemic Index on Glycaemia in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2018; 10(3):373.

Lifestyle Management: Standards of Medical Care in Diabetes-2019. Diabetes Care. 2019; 42(Suppl 1):S46-S60.

Elia M, Ceriello A, Laube H, Sinclair AJ, Engfer M, Stratton RJ. Enteral nutritional support and use of diabetes-specific formulas for patients with diabetes: a systematic review and meta-analysis. Diabetes Care. 2005; 28(9):2267-79.

Ojo O, Brooke J. Evaluation of the role of enteral nutrition in managing patients with diabetes: a systematic review. Nutrients. 2014; 6(11):5142-52.

Ojo O, Weldon SM, Thompson T, Crockett R, Wang XH. The Effect of Diabetes-Specific Enteral Nutrition Formula on Cardiometabolic Parameters in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. Nutrients. 2019; 11(8):1905.

Su HY, Tsang MW, Huang SY, Mechanick JI, Sheu WH, Marchetti A. Transculturalization of a diabetes-specific nutrition algorithm: Asian application. Curr Diab Rep. 2012; 12(2):213-9.

Mechanick JI, Marchetti AE, Apovian C, Benchimol AK, Bisschop PH, Bolio-Galvis A, et al. Diabetes-specific nutrition algorithm: a transcultural program to optimize diabetes and prediabetes care. Curr Diab Rep. 2012; 12(2):180-94.

Parillo M, Rivellese AA, Ciardullo AV, Capaldo B, Giacco A, Genovese S, et al. A high-monounsaturated-fat/low-carbohydrate diet improves peripheral insulin sensitivity in non-insulin-dependent diabetic patients. Metabolism. 1992; 41(12):1373-8.

Paniagua JA, de la Sacristana AG, Sanchez E, Romero I, Vidal-Puig A, Berral FJ, et al. A MUFA-rich diet improves posprandial glucose, lipid and GLP-1 responses in insulin-resistant subjects. J Am Coll Nutr. 2007; 26(5):434-44.

Kris-Etherton PM, Pearson TA, Wan Y, Hargrove RL, Moriarty K, Fishell V, et al. High-monounsaturated fatty acid diets lower both plasma cholesterol and triacylglycerol concentrations. Am J Clin Nutr. 1999; 70(6):1009-15.

Garg A, Bonanome A, Grundy SM, Zhang ZJ, Unger RH. Comparison of a high-carbohydrate diet with a high-monounsaturated-fat diet in patients with non-insulin-dependent diabetes mellitus. N Engl J Med. 1988; 319(13):829-34.

Cavalot F, Petrelli A, Traversa M, Bonomo K, Fiora E, Conti M, et al. Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study. J Clin Endocrinol Metab. 2006; 91(3):813-9.

Hanefeld M, Fischer S, Julius U, Schulze J, Schwanebeck U, Schmechel H, et al. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia. 1996; 39(12):1577-83.

Gerich JE. Clinical significance, pathogenesis, and management of postprandial hyperglycemia. Arch Intern Med. 2003; 163(11):1306-16.

de Vegt F, Dekker JM, Ruhe HG, Stehouwer CD, Nijpels G, Bouter LM, et al. Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia. 1999; 42(8):926-31.

Garcia-Rodriguez, Mesa MD, Olza J, G Buccianti G, Pérez M, Moreno-Torres R, et al. Postprandial glucose, insulin and gastrointestinal hormones in healthy and diabetic subjects fed a fructose-free and resistant starch type IV-enriched enteral formula. Eur J Nutr. 2013; 52(6):1569-78.

Tsang MW. The management of type 2 diabetic patients with hypoglycaemic agents. ISRN Endocrinol. 2012; 2012: 478120.

Downloads

Published

2021-04-06

Versions

How to Cite

Phanachet, P., Shantavasinkul, P. C., Lepananon, T., Taonam, N., Tongchom, W., Boonpattararaksa, J., Sittikho, N., Pichitchaipitak, O., Tontrakulrat, N., Hawkinson, A., & Warodomwichit, D. (2021). Efficacy and Safety of a Diabetes Specific Formula in Patients with Type 2 Diabetes Mellitus: A Randomized, Open-label, Crossover Study. Journal of Nutrition Association of Thailand (Online), 56(1), 1–12. Retrieved from https://he01.tci-thaijo.org/index.php/JNAT/article/view/244903

Issue

Section

Research article